Regulated Gas
Compare Stocks
5 / 10Stock Comparison
OPAL vs GEVO vs CLNE vs GPRE vs REX
Revenue, margins, valuation, and 5-year total return — side by side.
Chemicals - Specialty
Oil & Gas Refining & Marketing
Chemicals - Specialty
Chemicals - Specialty
OPAL vs GEVO vs CLNE vs GPRE vs REX — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Regulated Gas | Chemicals - Specialty | Oil & Gas Refining & Marketing | Chemicals - Specialty | Chemicals - Specialty |
| Market Cap | $54M | $493M | $507M | $1.15B | $1.60B |
| Revenue (TTM) | $349M | $174M | $439M | $1.94B | $651M |
| Net Income (TTM) | $15M | $-11M | $-99M | $-15M | $50M |
| Gross Margin | 28.1% | 23.4% | 11.7% | 1.8% | 12.7% |
| Operating Margin | 1.4% | -4.6% | 7.4% | 1.2% | 8.6% |
| Forward P/E | 15.6x | — | — | 46.6x | 62.8x |
| Total Debt | $365M | $168M | $99M | $508M | $21M |
| Cash & Equiv. | $24M | $1M | $158M | $182M | $196M |
OPAL vs GEVO vs CLNE vs GPRE vs REX — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 21 | May 26 | Return |
|---|---|---|---|
| OPAL Fuels Inc. (OPAL) | 100 | 24.0 | -76.0% |
| Gevo, Inc. (GEVO) | 100 | 26.9 | -73.1% |
| Clean Energy Fuels … (CLNE) | 100 | 29.2 | -70.8% |
| Green Plains Inc. (GPRE) | 100 | 51.6 | -48.4% |
| REX American Resour… (REX) | 100 | 304.3 | +204.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: OPAL vs GEVO vs CLNE vs GPRE vs REX
Each card shows where this stock fits in a portfolio — not just who wins on paper.
OPAL is the #2 pick in this set and the best alternative if income & stability is your priority.
- Dividend streak 0 yrs, beta 1.58, yield 15.3%
- Lower P/E (15.6x vs 62.8x)
- 15.3% yield; the other 4 pay no meaningful dividend
GEVO ranks third and is worth considering specifically for growth exposure.
- Rev growth 8.5%, EPS growth 58.8%, 3Y rev CAGR 415.1%
- 8.5% revenue growth vs REX's -22.9%
Among these 5 stocks, CLNE doesn't own a clear edge in any measured category.
GPRE is the clearest fit if your priority is momentum.
- +336.6% vs OPAL's -0.4%
REX carries the broadest edge in this set and is the clearest fit for long-term compounding and sleep-well-at-night.
- 464.7% 10Y total return vs GPRE's 21.3%
- Lower volatility, beta 0.36, Low D/E 3.3%, current ratio 8.64x
- Beta 0.36, current ratio 8.64x
- 7.7% margin vs CLNE's -22.7%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 8.5% revenue growth vs REX's -22.9% | |
| Value | Lower P/E (15.6x vs 62.8x) | |
| Quality / Margins | 7.7% margin vs CLNE's -22.7% | |
| Stability / Safety | Beta 0.36 vs GEVO's 1.64, lower leverage | |
| Dividends | 15.3% yield; the other 4 pay no meaningful dividend | |
| Momentum (1Y) | +336.6% vs OPAL's -0.4% | |
| Efficiency (ROA) | 6.7% ROA vs CLNE's -9.2%, ROIC 11.4% vs -9.4% |
OPAL vs GEVO vs CLNE vs GPRE vs REX — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
OPAL vs GEVO vs CLNE vs GPRE vs REX — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
REX leads in 3 of 6 categories
OPAL leads 1 • GEVO leads 0 • CLNE leads 0 • GPRE leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — OPAL and REX each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
GPRE is the larger business by revenue, generating $1.9B annually — 11.1x GEVO's $174M. REX is the more profitable business, keeping 7.7% of every revenue dollar as net income compared to CLNE's -22.7%. On growth, GEVO holds the edge at +47.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $349M | $174M | $439M | $1.9B | $651M |
| EBITDAEarnings before interest/tax | $28M | $18M | $62M | $122M | $67M |
| Net IncomeAfter-tax profit | $15M | -$11M | -$99M | -$15M | $50M |
| Free Cash FlowCash after capex | -$34M | -$35M | $19M | $90M | $18M |
| Gross MarginGross profit ÷ Revenue | +28.1% | +23.4% | +11.7% | +1.8% | +12.7% |
| Operating MarginEBIT ÷ Revenue | +1.4% | -4.6% | +7.4% | +1.2% | +8.6% |
| Net MarginNet income ÷ Revenue | +4.2% | -6.6% | -22.7% | -0.8% | +7.7% |
| FCF MarginFCF ÷ Revenue | -9.8% | -19.9% | +4.3% | +4.7% | +2.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | +24.7% | +47.5% | +13.3% | -25.9% | +0.4% |
| EPS Growth (YoY)Latest quarter vs prior year | +2.7% | +3.8% | +90.0% | +134.2% | +2.9% |
Valuation Metrics
OPAL leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 15.6x trailing earnings, OPAL trades at a 47% valuation discount to REX's 29.5x P/E. On an enterprise value basis, OPAL's 14.0x EV/EBITDA is more attractive than GPRE's 103.8x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $54M | $493M | $507M | $1.1B | $1.6B |
| Enterprise ValueMkt cap + debt − cash | $395M | $659M | $448M | $1.5B | $1.4B |
| Trailing P/EPrice ÷ TTM EPS | 15.60x | -14.50x | -2.29x | -9.14x | 29.50x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | — | 46.62x | 62.81x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | 0.55x |
| EV / EBITDAEnterprise value multiple | 14.03x | 102.12x | 94.64x | 103.82x | 16.60x |
| Price / SalesMarket cap ÷ Revenue | 0.15x | 3.07x | 1.19x | 0.55x | 2.50x |
| Price / BookPrice ÷ Book value/share | 0.14x | 1.01x | 0.90x | 1.44x | 2.67x |
| Price / FCFMarket cap ÷ FCF | — | — | 8.47x | 17.84x | — |
Profitability & Efficiency
REX leads this category, winning 8 of 9 comparable metrics.
Profitability & Efficiency
REX delivers a 7.7% return on equity — every $100 of shareholder capital generates $8 in annual profit, vs $-17 for CLNE. REX carries lower financial leverage with a 0.03x debt-to-equity ratio, signaling a more conservative balance sheet compared to OPAL's 0.73x. On the Piotroski fundamental quality scale (0–9), OPAL scores 5/9 vs GPRE's 4/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +3.1% | -2.4% | -17.2% | -2.0% | +7.7% |
| ROA (TTM)Return on assets | +1.6% | -1.7% | -9.2% | -1.0% | +6.7% |
| ROICReturn on invested capital | +0.5% | -2.8% | -9.4% | -5.2% | +11.4% |
| ROCEReturn on capital employed | +0.6% | -3.1% | -9.4% | -6.2% | +10.1% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 4 | 5 | 4 | 5 |
| Debt / EquityFinancial leverage | 0.73x | 0.36x | 0.18x | 0.66x | 0.03x |
| Net DebtTotal debt minus cash | $341M | $166M | -$59M | $326M | -$175M |
| Cash & Equiv.Liquid assets | $24M | $1M | $158M | $182M | $196M |
| Total DebtShort + long-term debt | $365M | $168M | $99M | $508M | $21M |
| Interest CoverageEBIT ÷ Interest expense | 0.18x | -0.04x | -1.07x | -0.08x | — |
Total Returns (Dividends Reinvested)
REX leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in REX five years ago would be worth $34,996 today (with dividends reinvested), compared to $2,388 for OPAL. Over the past 12 months, GPRE leads with a +336.6% total return vs OPAL's -0.4%. The 3-year compound annual growth rate (CAGR) favors REX at 50.8% vs OPAL's -29.2% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -1.7% | -1.5% | +6.9% | +60.1% | +50.2% |
| 1-Year ReturnPast 12 months | -0.4% | +88.0% | +44.4% | +336.6% | +147.6% |
| 3-Year ReturnCumulative with dividends | -64.5% | +65.0% | -46.3% | -46.8% | +243.1% |
| 5-Year ReturnCumulative with dividends | -76.1% | -65.2% | -73.8% | -48.5% | +250.0% |
| 10-Year ReturnCumulative with dividends | -76.1% | -98.6% | -26.9% | +21.3% | +464.7% |
| CAGR (3Y)Annualised 3-year return | -29.2% | +18.2% | -18.7% | -19.0% | +50.8% |
Risk & Volatility
REX leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
REX is the less volatile stock with a 0.36 beta — it tends to amplify market swings less than GEVO's 1.64 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. REX currently trades 91.2% from its 52-week high vs OPAL's 57.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.58x | 1.64x | 1.19x | 1.22x | 0.36x |
| 52-Week HighHighest price in past year | $4.08 | $2.97 | $3.11 | $18.94 | $53.36 |
| 52-Week LowLowest price in past year | $1.65 | $1.01 | $1.56 | $3.39 | $19.44 |
| % of 52W HighCurrent price vs 52-week peak | +57.4% | +68.4% | +74.3% | +86.9% | +91.2% |
| RSI (14)Momentum oscillator 0–100 | 48.0 | 53.5 | 44.6 | 54.3 | 59.1 |
| Avg Volume (50D)Average daily shares traded | 198K | 4.5M | 1.3M | 1.5M | 204K |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Analyst consensus: GEVO as "Buy", CLNE as "Buy", GPRE as "Buy", REX as "Buy". Consensus price targets imply 72.4% upside for GEVO (target: $4) vs -16.2% for GPRE (target: $14). OPAL is the only dividend payer here at 15.29% yield — a key consideration for income-focused portfolios.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | — | $3.50 | $3.50 | $13.80 | $60.00 |
| # AnalystsCovering analysts | — | 14 | 22 | 20 | 3 |
| Dividend YieldAnnual dividend ÷ price | +15.3% | — | — | — | — |
| Dividend StreakConsecutive years of raises | 0 | — | — | 0 | — |
| Dividend / ShareAnnual DPS | $0.36 | — | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +1.6% | +2.6% | +0.9% |
REX leads in 3 of 6 categories (Profitability & Efficiency, Total Returns). OPAL leads in 1 (Valuation Metrics). 1 tied.
OPAL vs GEVO vs CLNE vs GPRE vs REX: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is OPAL or GEVO or CLNE or GPRE or REX a better buy right now?
For growth investors, Gevo, Inc.
(GEVO) is the stronger pick with 849. 3% revenue growth year-over-year, versus -22. 9% for REX American Resources Corporation (REX). OPAL Fuels Inc. (OPAL) offers the better valuation at 15. 6x trailing P/E, making it the more compelling value choice. Analysts rate Gevo, Inc. (GEVO) a "Buy" — based on 14 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — OPAL or GEVO or CLNE or GPRE or REX?
On trailing P/E, OPAL Fuels Inc.
(OPAL) is the cheapest at 15. 6x versus REX American Resources Corporation at 29. 5x. On forward P/E, Green Plains Inc. is actually cheaper at 46. 6x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — OPAL or GEVO or CLNE or GPRE or REX?
Over the past 5 years, REX American Resources Corporation (REX) delivered a total return of +250.
0%, compared to -76. 1% for OPAL Fuels Inc. (OPAL). Over 10 years, the gap is even starker: REX returned +464. 7% versus GEVO's -98. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — OPAL or GEVO or CLNE or GPRE or REX?
By beta (market sensitivity over 5 years), REX American Resources Corporation (REX) is the lower-risk stock at 0.
36β versus Gevo, Inc. 's 1. 64β — meaning GEVO is approximately 352% more volatile than REX relative to the S&P 500. On balance sheet safety, REX American Resources Corporation (REX) carries a lower debt/equity ratio of 3% versus 73% for OPAL Fuels Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — OPAL or GEVO or CLNE or GPRE or REX?
By revenue growth (latest reported year), Gevo, Inc.
(GEVO) is pulling ahead at 849. 3% versus -22. 9% for REX American Resources Corporation (REX). On earnings-per-share growth, the picture is similar: OPAL Fuels Inc. grew EPS 638. 9% year-over-year, compared to -173. 0% for Clean Energy Fuels Corp.. Over a 3-year CAGR, GEVO leads at 415. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — OPAL or GEVO or CLNE or GPRE or REX?
REX American Resources Corporation (REX) is the more profitable company, earning 9.
1% net margin versus -52. 3% for Clean Energy Fuels Corp. — meaning it keeps 9. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: REX leads at 10. 0% versus -22. 1% for CLNE. At the gross margin level — before operating expenses — GEVO leads at 30. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is OPAL or GEVO or CLNE or GPRE or REX more undervalued right now?
On forward earnings alone, Green Plains Inc.
(GPRE) trades at 46. 6x forward P/E versus 62. 8x for REX American Resources Corporation — 16. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for GEVO: 72. 4% to $3. 50.
08Which pays a better dividend — OPAL or GEVO or CLNE or GPRE or REX?
In this comparison, OPAL (15.
3% yield) pays a dividend. GEVO, CLNE, GPRE, REX do not pay a meaningful dividend and should not be held primarily for income.
09Is OPAL or GEVO or CLNE or GPRE or REX better for a retirement portfolio?
For long-horizon retirement investors, REX American Resources Corporation (REX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
36), +464. 7% 10Y return). Gevo, Inc. (GEVO) carries a higher beta of 1. 64 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (REX: +464. 7%, GEVO: -98. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between OPAL and GEVO and CLNE and GPRE and REX?
These companies operate in different sectors (OPAL (Utilities) and GEVO (Basic Materials) and CLNE (Energy) and GPRE (Basic Materials) and REX (Basic Materials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: OPAL is a small-cap high-growth stock; GEVO is a small-cap high-growth stock; CLNE is a small-cap quality compounder stock; GPRE is a small-cap quality compounder stock; REX is a small-cap quality compounder stock. OPAL pays a dividend while GEVO, CLNE, GPRE, REX do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.